
Sign up to save your podcasts
Or


In the face of a growing childhood obesity epidemic, some parents and clinicians are turning to new tools such as GLP-1 receptor agonists. This episode explores the implications of that trend.
A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2400703.
By NEJM Group4.7
3131 ratings
In the face of a growing childhood obesity epidemic, some parents and clinicians are turning to new tools such as GLP-1 receptor agonists. This episode explores the implications of that trend.
A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2400703.

321 Listeners

125 Listeners

6,441 Listeners

57 Listeners

92 Listeners

5 Listeners

60 Listeners

66 Listeners